← FDA DRUG APPROVALS

FDA ANDA · ANDA073058

FLUPHENAZINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA073058
TYPE
ANDA
ORIGINAL APPROVAL
1991-08-30
LATEST ACTION
2002-01-23
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

FLUPHENAZINE HYDROCHLORIDEDiscontinued
FLUPHENAZINE HYDROCHLORIDE 5MG/ML · CONCENTRATE · ORAL

Approval history

2002-01-23Manufacturing (CMC) · Supplement 8AP
2001-10-31Manufacturing (CMC) · Supplement 10AP
2001-10-31Manufacturing (CMC) · Supplement 9AP
2001-10-31Manufacturing (CMC) · Supplement 11AP
2001-02-26Manufacturing (CMC) · Supplement 7AP
1999-06-11Manufacturing (CMC) · Supplement 4AP
1999-03-23Manufacturing (CMC) · Supplement 5AP
1998-06-11Manufacturing (CMC) · Supplement 3AP
1997-06-23Manufacturing (CMC) · Supplement 2AP
1996-05-31Manufacturing (CMC) · Supplement 1AP
1991-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →